がん専門医の世界市場レポート 2025年

がん専門医の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR4.5％で242億4,000万米ドルに成長します。予測期間の成長は、精密医療と個別化治療、新たな治療法、世界的な腫瘍学共同研究、疫学的シフトと新たな課題、ヘルスケア政策、経済的要因に起因すると考えられます。予測期間における主な動向には、免疫療法の進歩、精密医療の統合、遠隔医療の拡大、データ主導の意思決定、共同ケアモデル、患者中心のケアなどがあります。

がんの有病率の増加は、今後のがん専門医市場の成長を大きく牽引すると予想されます。がんは、特定の体細胞の制御不能な増殖を特徴とする疾患であり、その後、他の部位に転移する可能性があります。がんの有病率は、特定の期間に特定の集団で新たに発生する症例の数を指します。がん専門医は、がんの診断と治療を専門とするヘルスケア専門家であり、患者の診察、病気の診断、治療法の特定を行います。例えば、米国を拠点とする政府機関である国立がん研究所は、2024年5月、米国におけるがん生存者数は約1,810万人であると報告しました。この数は2032年までに2,250万人に増加すると予測されています。さらに、2040年までに新たに発生するがん患者は年間2,990万人に達し、がんに関連した死亡者数は1,530万人に増加すると予測されています。したがって、がんの有病率の上昇ががん専門医市場を前進させています。

高齢者人口の増加は、がん専門医市場の拡大を支える重要な要因になると予想されます。60歳以上で構成される高齢者は、加齢とともにがんのリスクが高まるため、がんにかかりやすくなります。がん専門医の需要は、高齢者人口におけるがんの有病率の増加とともに上昇します。世界保健機関（WHO）によると、2030年までに世界の6人に1人が60歳以上になるといいます。高齢者の数は2020年には14億人に達し、2050年には2倍以上の21億人に達すると予測されています。したがって、高齢者人口の増加は、予測期間においてがん専門医市場にプラスの影響を与えると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のがん専門医市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のがん専門医市場：成長率分析
• 世界のがん専門医市場の実績：規模と成長、2019～2024年
• 世界のがん専門医市場の予測：規模と成長、2024～2029年、2034年
• 世界のがん専門医総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のがん専門医市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• がん診断
• がん治療
• 世界のがん専門医市場：適応症別、実績と予測、2019～2024年、2024～2029年、2034年
• 肺がん
• 大腸がん
• 乳がん
• 肝臓がん
• 膀胱がん
• 頭頸部がん
• 前立腺がん
• その他
• 世界のがん専門医市場：最終用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• 診断検査室
• 画像診断センター
• 専門クリニック
• 学術研究
• その他
• 世界のがん専門医市場：がん診断のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 画像検査
• 生検
• 血液検査
• 分子診断
• 遺伝子検査
• 世界のがん専門医市場：がん治療のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 化学療法
• 放射線治療
• 免疫療法
• 標的療法
• ホルモン療法
• 幹細胞移植

第7章 地域別・国別分析

• 世界のがん専門医市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のがん専門医市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• がん専門医市場：競合情勢
• がん専門医市場：企業プロファイル
  • Abramson Cancer Center Overview, Products and Services, Strategy and Financial Analysis
  • MD Anderson Cancer Center of the University of Texas Overview, Products and Services, Strategy and Financial Analysis
  • Lilavati Hospital & Research Centre Overview, Products and Services, Strategy and Financial Analysis
  • Mount Elizabeth Hospital Overview, Products and Services, Strategy and Financial Analysis
  • Mount Miriam Cancer Hospital Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Charite-Universitatsmedizin Berlin
• General Electric Healthcare
• F. Hoffmann-La Roche AG
• Pfizer Inc.
• Bayer AG
• Merck & Co. Inc.
• AbbVie Inc.
• Amgen Inc.
• Takeda Pharmaceuticals USA Inc.
• Becton Dickinson and Company
• Cook Medical LLC
• Terumo Corporation
• AngioDynamics Inc.
• Thermo Fisher Scientific Inc.
• Illumina Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• がん専門医市場2029年：新たな機会を提供する国
• がん専門医市場2029年：新たな機会を提供するセグメント
• がん専門医市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Oncologists are a specialized type of healthcare practitioner focused on the diagnosis and treatment of cancer. They play a crucial role in evaluating patients, diagnosing cancer, and recommending appropriate treatments, actively participating in the comprehensive care of cancer patients.

The primary areas of focus for oncologists are cancer diagnostics and cancer treatment. Cancer diagnostics involve testing procedures designed to confirm the presence of cancer and identify the specific tumor type. Common cancer types include lung cancer, colorectal cancer, breast cancer, liver cancer, bladder cancer, head and neck cancer, and prostate cancer. Oncologists work in various healthcare settings, including hospitals, diagnostic laboratories, diagnostic imaging centers, specialty clinics, academia, and other related institutions.

The oncologists market research report is one of a series of new reports from The Business Research Company that provides oncologists market statistics, including oncologists industry global market size, regional shares, competitors with an oncologists market share, detailed oncologists market segments, market trends and opportunities, and any further data you may need to thrive in the oncologists industry. This mobile wallet market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oncologists market size has grown marginally in recent years. It will grow from $19.93 billion in 2024 to $20.3 billion in 2025 at a compound annual growth rate (CAGR) of 1.9%. The growth in the historic period can be attributed to increasing cancer incidence, therapeutic advancements, aging population, healthcare infrastructure development, awareness and early detection programs.

The oncologists market size is expected to see steady growth in the next few years. It will grow to $24.24 billion in 2029 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to precision medicine and personalized therapies, emerging therapeutic modalities, global oncology collaboration, epidemiological shifts and new challenges, healthcare policy and economic factors. Major trends in the forecast period include immunotherapy advancements, precision medicine integration, telemedicine expansion, data-driven decision-making, collaborative care models, and patient-centric care.

The increasing prevalence of cancer is expected to significantly drive the growth of the oncologists market in the future. Cancer is a disease characterized by the uncontrolled growth of certain body cells, which can then spread to other areas. The prevalence of cancer refers to the number of new cases that occur in a specified population over a specific period. Oncologists are healthcare professionals specializing in the diagnosis and treatment of cancer; they are responsible for examining patients, diagnosing the disease, and identifying treatment options. For example, in May 2024, the National Cancer Institute, a U.S.-based government agency, reported that there were approximately 18.1 million cancer survivors in the United States. This number is projected to rise to 22.5 million by 2032. Furthermore, by 2040, the annual incidence of new cancer cases is expected to reach 29.9 million, with cancer-related deaths estimated to increase to 15.3 million. Therefore, the rising prevalence of cancer is propelling the oncologists market forward.

The growth of the aging population is expected to be a significant factor supporting the expansion of the oncologists' market. An aging population, comprising individuals aged 60 and above, is more susceptible to cancer as the risk of cancer increases with age. The demand for oncologists rises with the growing prevalence of cancer in the elderly population. According to the World Health Organization, by 2030, 1 in 6 people globally will be aged 60 or above. The number of elderly individuals reached 1.4 billion in 2020, and by 2050, it is projected to more than double, reaching 2.1 billion. Therefore, the increasing size of the aging population is expected to have a positive impact on the oncologists' market in the forecast period.

Major companies in the oncology market are focusing on establishing AI-precision oncology centers to enhance personalized cancer treatment, improve diagnostic accuracy, and optimize treatment plans based on individual patient data and tumor characteristics. AI-precision oncology centers are specialized medical facilities that employ artificial intelligence (AI) and machine learning technologies to deliver highly personalized cancer care. For example, in January 2024, Apollo Cancer Centre, an India-based hospital, launched its AI-precision oncology center. This facility aims to support oncologists, patients, and caregivers in achieving optimal outcomes within a defined timeframe by harnessing the capabilities of AI technology. The center uses AI technologies to provide precise diagnoses and real-time insights into patient conditions, enabling timely interventions and better management of cancer cases. Additionally, the center conducts comprehensive cancer risk assessments to identify patients who may benefit from targeted therapies or immunotherapy as part of their treatment plans.

Major companies in the oncologists' market are also establishing new collaborative networks to advance research and development efforts. In September 2023, Amgen launched the 'Amgen Partners of Choice' network, bringing together its oncology research and development experts with clinical leaders at eight global research centers. The network, part of Amgen's mission to enhance care through partnerships, fosters academic collaboration to advance innovative treatment options for patients with significant unmet needs.

In July 2024, Mumbai Oncocare (MOC) Cancer Care & Research Centre, an India-based hospital and physician clinic specializing in oncology care, merged with Hemato Oncology Clinic for an undisclosed amount. This merger enables Mumbai Oncocare to enhance its portfolio by leveraging Hemato Oncology's expertise, which includes a total of 40 medical oncologists and hematologists. Hemato Oncology Clinic is an India-based facility that provides advanced oncology care.

Major companies operating in the oncologists market include Abramson Cancer Center, MD Anderson Cancer Center of the University of Texas, Lilavati Hospital & Research Centre, Mount Elizabeth Hospital, Mount Miriam Cancer Hospital, Charite - Universitatsmedizin Berlin, General Electric Healthcare, F. Hoffmann-La Roche AG, Pfizer Inc., Bayer AG, Merck & Co. Inc., AbbVie Inc., Amgen Inc., Takeda Pharmaceuticals USA Inc., Becton Dickinson and Company, Cook Medical LLC, Terumo Corporation, AngioDynamics Inc., Thermo Fisher Scientific Inc., Illumina Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals Inc., Alexion Pharmaceuticals Inc., Incyte Corporation, Seattle Genetics Inc.

North America was the largest region in the oncologists market in 2024. The regions covered in the oncologists market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the oncologists market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oncologists market includes revenues earned by entities by providing diagnoses and treats cancer, radiation oncologists and surgical oncologists. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oncologists Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oncologists market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oncologists ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oncologists market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Cancer Diagnostics And Treatment: Cancer Diagnostics; Cancer Treatment
• 2) By Indication: Lungs Cancer; Colorectal Cancer; Breast Cancer; Liver Cancer; Bladder Cancer; Head And Neck Cancer; Prostate Cancer; Other Indications
• 3) By End Use: Hospitals; Diagnostic Laboratories; Diagnostic Imaging Centers; Specialty Clinics; Academia; Other End Uses
• Subsegments:
• 1) By Cancer Diagnostics: Imaging Tests; Biopsy; Blood Tests; Molecular Diagnostics; Genetic Testing
• 2) By Cancer Treatment: Chemotherapy; Radiation Therapy; Immunotherapy; Targeted Therapy; Hormone Therapy; Stem Cell Transplant
• Companies Mentioned: Abramson Cancer Center; MD Anderson Cancer Center of the University of Texas; Lilavati Hospital & Research Centre; Mount Elizabeth Hospital; Mount Miriam Cancer Hospital
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Oncologists Market Characteristics

3. Oncologists Market Trends And Strategies

4. Oncologists Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Oncologists Growth Analysis And Strategic Analysis Framework

• 5.1. Global Oncologists PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Oncologists Market Growth Rate Analysis
• 5.4. Global Oncologists Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Oncologists Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Oncologists Total Addressable Market (TAM)

6. Oncologists Market Segmentation

• 6.1. Global Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer Diagnostics
• Cancer Treatment
• 6.2. Global Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lungs Cancer
• Colorectal Cancer
• Breast Cancer
• Liver Cancer
• Bladder Cancer
• Head and Neck Cancer
• Prostate Cancer
• Other Indications
• 6.3. Global Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Diagnostic Imaging Centers
• Specialty Clinics
• Academia
• Other End Uses
• 6.4. Global Oncologists Market, Sub-Segmentation Of Cancer Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Tests
• Biopsy
• Blood Tests
• Molecular Diagnostics
• Genetic Testing
• 6.5. Global Oncologists Market, Sub-Segmentation Of Cancer Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Radiation Therapy
• Immunotherapy
• Targeted Therapy
• Hormone Therapy
• Stem Cell Transplant

7. Oncologists Market Regional And Country Analysis

• 7.1. Global Oncologists Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Oncologists Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Oncologists Market

• 8.1. Asia-Pacific Oncologists Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Oncologists Market

• 9.1. China Oncologists Market Overview
• 9.2. China Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Oncologists Market

• 10.1. India Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Oncologists Market

• 11.1. Japan Oncologists Market Overview
• 11.2. Japan Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Oncologists Market

• 12.1. Australia Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Oncologists Market

• 13.1. Indonesia Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Oncologists Market

• 14.1. South Korea Oncologists Market Overview
• 14.2. South Korea Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Oncologists Market

• 15.1. Western Europe Oncologists Market Overview
• 15.2. Western Europe Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Oncologists Market

• 16.1. UK Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Oncologists Market

• 17.1. Germany Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Oncologists Market

• 18.1. France Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Oncologists Market

• 19.1. Italy Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Oncologists Market

• 20.1. Spain Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Oncologists Market

• 21.1. Eastern Europe Oncologists Market Overview
• 21.2. Eastern Europe Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Oncologists Market

• 22.1. Russia Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Oncologists Market

• 23.1. North America Oncologists Market Overview
• 23.2. North America Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Oncologists Market

• 24.1. USA Oncologists Market Overview
• 24.2. USA Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Oncologists Market

• 25.1. Canada Oncologists Market Overview
• 25.2. Canada Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Oncologists Market

• 26.1. South America Oncologists Market Overview
• 26.2. South America Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Oncologists Market

• 27.1. Brazil Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Oncologists Market

• 28.1. Middle East Oncologists Market Overview
• 28.2. Middle East Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Oncologists Market

• 29.1. Africa Oncologists Market Overview
• 29.2. Africa Oncologists Market, Segmentation By Cancer Diagnostics And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Oncologists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Oncologists Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Oncologists Market Competitive Landscape And Company Profiles

• 30.1. Oncologists Market Competitive Landscape
• 30.2. Oncologists Market Company Profiles
  • 30.2.1. Abramson Cancer Center Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. MD Anderson Cancer Center of the University of Texas Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Lilavati Hospital & Research Centre Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Mount Elizabeth Hospital Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Mount Miriam Cancer Hospital Overview, Products and Services, Strategy and Financial Analysis

31. Oncologists Market Other Major And Innovative Companies

• 31.1. Charite - Universitatsmedizin Berlin
• 31.2. General Electric Healthcare
• 31.3. F. Hoffmann-La Roche AG
• 31.4. Pfizer Inc.
• 31.5. Bayer AG
• 31.6. Merck & Co. Inc.
• 31.7. AbbVie Inc.
• 31.8. Amgen Inc.
• 31.9. Takeda Pharmaceuticals USA Inc.
• 31.10. Becton Dickinson and Company
• 31.11. Cook Medical LLC
• 31.12. Terumo Corporation
• 31.13. AngioDynamics Inc.
• 31.14. Thermo Fisher Scientific Inc.
• 31.15. Illumina Inc.

32. Global Oncologists Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oncologists Market

34. Recent Developments In The Oncologists Market

35. Oncologists Market High Potential Countries, Segments and Strategies

• 35.1 Oncologists Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Oncologists Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Oncologists Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer